American Association for the Study of Liver Diseases and the International Liver Transplantation Society Course (AASLD/ILTS), Part 2: Substance Use Disorders (Ticketed) | AASLD

American Association for the Study of Liver Diseases and the International Liver Transplantation Society Course (AASLD/ILTS), Part 2: Substance Use Disorders (Ticketed)

Nov 08 2025
Convention Center: Room 202, Level 2
9:45 AM - 10:45 AM
Ticketed Event

World Class Speakers

Vijay H. Shah, MD, FAASLD
Presenter

Vijay H. Shah, MD, FAASLD

Mayo Clinic Rochester
Nazia Selzner, MD, PhD
Presenter

Nazia Selzner, MD, PhD

University of Toronto
Norah Terrault, MD, MPH, FAASLD
Presenter

Norah Terrault, MD, MPH, FAASLD

University of Southern California
Ramesh Batra, MD, MA(Bioethics), FRCS
Presenter

Ramesh Batra, MD, MA(Bioethics), FRCS

University of Arizona
Ryutaro P Hirose, MD
Moderator

Ryutaro P Hirose, MD

University of Washington Medical Center
Raiya Sarwar, MD
Moderator

Raiya Sarwar, MD

NYU Langone

Description

Delve into the complexities of liver transplantation among patients with alcohol-associated liver disease (ALD). Topics include the clinical and logistical resources required, ethical considerations—especially in living donor contexts—and the critical role of relapse prevention and psychosocial support in long-term outcomes.

Journey Maps

Presentations

9:45 AM - 9:55 AM
Oct 10 2026
Convention Center - Room 202, Level 2

Alcohol-Associated Hepatitis: Is It Time to Standardize Patient Selection?

Vijay H. Shah, MD, FAASLD , Presenter
Transplant
9:55 AM - 10:05 AM
Oct 10 2026
Convention Center - Room 202, Level 2

Resource Utilization for Transplantation of Patients With Alcohol-Associated Hepatitis

Nazia Selzner, MD, PhD , Presenter
Transplant
10:05 AM - 10:15 AM
Oct 10 2026
Convention Center - Room 202, Level 2

Preventing Alcohol Relapse: Before and After Transplant

Norah Terrault, MD, MPH, FAASLD , Presenter
Transplant
10:15 AM - 10:25 AM
Oct 10 2026
Convention Center - Room 202, Level 2

Ethical Considerations for Transplanting a Patient With Alcohol-Associated Liver Disease Including Living Donor Inequities

Ramesh Batra, MD, MA(Bioethics), FRCS , Presenter
Transplant
10:25 AM - 10:45 AM
Oct 10 2026
Convention Center - Room 202, Level 2

Q&A

Raiya Sarwar, MD , Moderator
Transplant

Objectives

  • Discuss current insights into the management of alcohol use and liver transplantation.
  • List resources required for transplantation and management of patients with alcohol-associated liver disease (ALD).
  • Review ethical issues regarding liver transplantation of patients with ALD, particularly with a living donor.
  • Explain the requirement and necessity of relapse prevention treatment in patients with ALD.
Chair

Ryutaro P Hirose, MD

University of Washington Medical Center
Chair

Ramesh Batra, MD, MA(Bioethics), FRCS

University of Arizona